We are live on ! Find out more
NVNO

enVVeno Medical

4 hedge funds and large institutions have $25K invested in enVVeno Medical in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0%0% (-0%)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

33% less funds holding

Funds holding: 64 (-2)

81% less capital invested

Capital invested by funds: $129K → $25K (-$104K)

Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

NVNO Hedge Fund Activity: Q1 2020 in Review

4 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q1 2020, worth a combined $25K — down 81% from $129K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NVNO and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $12.3K. The largest seller was Jane Street, exiting entirely with an estimated $62K sold.

  • 4 institutional investors held enVVeno Medical (NVNO) as of Q1 2020, down from 6 in Q4 2019.
  • Funds reported $25K of enVVeno Medical stock for Q1 2020, down 81% quarter-over-quarter.
  • 3 funds opened new enVVeno Medical positions in Q1 2020 and 4 closed out, a net change of -1 holder.
  • The largest enVVeno Medical buyer in Q1 2020 was Susquehanna International Group, an estimated $12.3K added.
  • The largest enVVeno Medical seller in Q1 2020 was Jane Street, an estimated $62K sold.

Based on aggregated 13F filings for Q1 2020.